Emerging Innovations Reshaping the Alpha Fetoprotein Tumor Market
The Alpha Fetoprotein Tumor Market is expanding as oncologists and hepatologists increasingly rely on this critical biomarker for liver cancer screening, diagnosis, and treatment monitoring. Alpha fetoprotein (AFP) is a glycoprotein produced by the fetal yolk sac and liver, with elevated serum levels serving as a key indicator of hepatocellular carcinoma (HCC), germ cell tumors, and certain...
0 Comentários 0 Compartilhamentos 8 Visualizações 0 Anterior